Trial intelligence / Profile preview

Long-term Mometasone Furoate in Perennial Allergic Rhinitis

NCT00732368Phase 3Completed

Sponsor
Organon & Co.
Start
May 2005
Primary completion
Jan 2006
Modality
Small Molecules
01

Overview

A Phase 3 trial of mometasone furoate nasal spray in perennial allergic rhinitis (PAR), sponsored by Organon & Co.. Started May 2005; status: completed.

02

Drugs

mometasone furoate nasal spray
03

Conditions

perennial allergic rhinitis (PAR)

Beyond the preview

Go deeper on NCT00732368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00732368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call